Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort

Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we invest...

Full description

Saved in:
Bibliographic Details
Published in:Translational psychiatry 2022-09, Vol.12 (1), p.377-377, Article 377
Main Authors: Byrne, Jonah F., Healy, Colm, Mongan, David, Susai, Subash Raj, Zammit, Stan, Fӧcking, Melanie, Cannon, Mary, Cotter, David R.
Format: Article
Language:English
Subjects:
13/21
631/378
692/53
692/699/476/1414
692/699/476/1799
Adult
Behavioral Sciences
Biological Psychology
Case-Control Studies
Clinical trials
Cohort Studies
Humans
Medicine
Medicine & Public Health
Mental disorders
Mental Disorders - diagnosis
Neurosciences
Pharmacotherapy
Psychiatry
Psychosis
Psychotic Disorders - diagnosis
Receptors, Urokinase Plasminogen Activator
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3
cites cdi_FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3
container_end_page 377
container_issue 1
container_start_page 377
container_title Translational psychiatry
container_volume 12
creator Byrne, Jonah F.
Healy, Colm
Mongan, David
Susai, Subash Raj
Zammit, Stan
Fӧcking, Melanie
Cannon, Mary
Cotter, David R.
description Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we investigated whether different subgroups of individuals exist across psychiatric disorders, based on their inflammatory biomarker signatures. We measured the plasma concentrations of 17 inflammatory markers and receptors in 380 participants with psychotic disorder, depressive disorder or generalised anxiety disorder and 399 controls without psychiatric symptoms from the ALSPAC cohort at age 24. We employed a semi-supervised clustering algorithm, which discriminates multiple clusters of psychiatric disorder cases from controls. The best fit was for a two-cluster model of participants with psychiatric disorders (Adjusted Rand Index (ARI) = 0.52 ± 0.01) based on the inflammatory markers. Permutation analysis indicated the stability of the clustering solution performed better than chance (ARI = 0.43 ± 0.11; p  
doi_str_mv 10.1038/s41398-022-02142-2
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_e5e566e3f2844aed9a19025e63d94ec3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_e5e566e3f2844aed9a19025e63d94ec3</doaj_id><sourcerecordid>2712849598</sourcerecordid><originalsourceid>FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3</originalsourceid><addsrcrecordid>eNp9kl2L1DAUhoso7rLuH_BCAt54U81nm3ohDIMfCwMKrtchk5x2MrTJmKQL81_8sWan67rrhYXQkvOcJ83hraqXBL8lmMl3iRPWyRpTWhbhtKZPqnNKhKwZkfLpg--z6jKlPS6P4JK05Hl1xhosBZX8vPp1HbVP1unBh5SdQc73o54mnUM8ojRvhxjmQ0J6Cn5Ah3Q0O6dzLKB1KUQLsdS8RXkHLqIII9xobwDlgGIYAfWzN9kF7_zwHmnkIWWwyOgEtQk-FwalPNsjCv2tA60237-t1siEXYj5RfWs12OCy7v3RfXj08fr9Zd68_Xz1Xq1qY3gONeWbMFKDD2BHhtuul5yAUISjImxgtm-JS3thZUt1lQ2FtOmKQ2i1cA0seyiulq8Nui9OkQ36XhUQTt12ghxUDqW4YygoIibBlhfpsc12E6TDlMBDbMdB8OK68PiOszbCayBckk9PpI-rni3U0O4UR1vGOGiCN7cCWL4OZd5qcklA-OoPYQ5KdqScnYnOlnQ1_-g-zBHX0Z1ogiRjOJC0YUyMaQUob__GYLVbZbUkiVVsqROWVK0NL16eI37lj_JKQBbgFRKfoD49-z_aH8DPXXYJg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2712118320</pqid></control><display><type>article</type><title>Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort</title><source>Nexis UK</source><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Springer Nature - nature.com Journals - Fully Open Access</source><creator>Byrne, Jonah F. ; Healy, Colm ; Mongan, David ; Susai, Subash Raj ; Zammit, Stan ; Fӧcking, Melanie ; Cannon, Mary ; Cotter, David R.</creator><creatorcontrib>Byrne, Jonah F. ; Healy, Colm ; Mongan, David ; Susai, Subash Raj ; Zammit, Stan ; Fӧcking, Melanie ; Cannon, Mary ; Cotter, David R.</creatorcontrib><description>Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we investigated whether different subgroups of individuals exist across psychiatric disorders, based on their inflammatory biomarker signatures. We measured the plasma concentrations of 17 inflammatory markers and receptors in 380 participants with psychotic disorder, depressive disorder or generalised anxiety disorder and 399 controls without psychiatric symptoms from the ALSPAC cohort at age 24. We employed a semi-supervised clustering algorithm, which discriminates multiple clusters of psychiatric disorder cases from controls. The best fit was for a two-cluster model of participants with psychiatric disorders (Adjusted Rand Index (ARI) = 0.52 ± 0.01) based on the inflammatory markers. Permutation analysis indicated the stability of the clustering solution performed better than chance (ARI = 0.43 ± 0.11; p  &lt; 0.001), and the clusters explained the inflammatory marker data better than a Gaussian distribution ( p  = 0.021). Cluster 2 exhibited marked increases in sTNFR1/2, suPAR, sCD93 and sIL-2RA, compared to cluster 1. Participants in the cluster exhibiting higher inflammation were less likely to be in employment, education or training, indicating poorer role functioning. This study found evidence for a novel pattern of inflammatory markers specific to psychiatric disorders and strongly associated with a transdiagnostic measure of illness severity. sTNFR1/2, suPAR, sCD93 and sIL-2RA could be used to stratify clinical trials of anti-inflammatory therapies for psychiatric disorders.</description><identifier>ISSN: 2158-3188</identifier><identifier>EISSN: 2158-3188</identifier><identifier>DOI: 10.1038/s41398-022-02142-2</identifier><identifier>PMID: 36085284</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/21 ; 631/378 ; 692/53 ; 692/699/476/1414 ; 692/699/476/1799 ; Adult ; Behavioral Sciences ; Biological Psychology ; Case-Control Studies ; Clinical trials ; Cohort Studies ; Humans ; Medicine ; Medicine &amp; Public Health ; Mental disorders ; Mental Disorders - diagnosis ; Neurosciences ; Pharmacotherapy ; Psychiatry ; Psychosis ; Psychotic Disorders - diagnosis ; Receptors, Urokinase Plasminogen Activator ; Young Adult</subject><ispartof>Translational psychiatry, 2022-09, Vol.12 (1), p.377-377, Article 377</ispartof><rights>The Author(s) 2022</rights><rights>2022. The Author(s).</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3</citedby><cites>FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3</cites><orcidid>0000-0002-7046-0630 ; 0000-0002-6299-2952 ; 0000-0003-4308-0648 ; 0000-0001-7931-9636</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2712118320/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2712118320?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,724,777,781,882,25734,27905,27906,36993,36994,44571,53772,53774,74875</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36085284$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Byrne, Jonah F.</creatorcontrib><creatorcontrib>Healy, Colm</creatorcontrib><creatorcontrib>Mongan, David</creatorcontrib><creatorcontrib>Susai, Subash Raj</creatorcontrib><creatorcontrib>Zammit, Stan</creatorcontrib><creatorcontrib>Fӧcking, Melanie</creatorcontrib><creatorcontrib>Cannon, Mary</creatorcontrib><creatorcontrib>Cotter, David R.</creatorcontrib><title>Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort</title><title>Translational psychiatry</title><addtitle>Transl Psychiatry</addtitle><addtitle>Transl Psychiatry</addtitle><description>Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we investigated whether different subgroups of individuals exist across psychiatric disorders, based on their inflammatory biomarker signatures. We measured the plasma concentrations of 17 inflammatory markers and receptors in 380 participants with psychotic disorder, depressive disorder or generalised anxiety disorder and 399 controls without psychiatric symptoms from the ALSPAC cohort at age 24. We employed a semi-supervised clustering algorithm, which discriminates multiple clusters of psychiatric disorder cases from controls. The best fit was for a two-cluster model of participants with psychiatric disorders (Adjusted Rand Index (ARI) = 0.52 ± 0.01) based on the inflammatory markers. Permutation analysis indicated the stability of the clustering solution performed better than chance (ARI = 0.43 ± 0.11; p  &lt; 0.001), and the clusters explained the inflammatory marker data better than a Gaussian distribution ( p  = 0.021). Cluster 2 exhibited marked increases in sTNFR1/2, suPAR, sCD93 and sIL-2RA, compared to cluster 1. Participants in the cluster exhibiting higher inflammation were less likely to be in employment, education or training, indicating poorer role functioning. This study found evidence for a novel pattern of inflammatory markers specific to psychiatric disorders and strongly associated with a transdiagnostic measure of illness severity. sTNFR1/2, suPAR, sCD93 and sIL-2RA could be used to stratify clinical trials of anti-inflammatory therapies for psychiatric disorders.</description><subject>13/21</subject><subject>631/378</subject><subject>692/53</subject><subject>692/699/476/1414</subject><subject>692/699/476/1799</subject><subject>Adult</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Case-Control Studies</subject><subject>Clinical trials</subject><subject>Cohort Studies</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mental disorders</subject><subject>Mental Disorders - diagnosis</subject><subject>Neurosciences</subject><subject>Pharmacotherapy</subject><subject>Psychiatry</subject><subject>Psychosis</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Receptors, Urokinase Plasminogen Activator</subject><subject>Young Adult</subject><issn>2158-3188</issn><issn>2158-3188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp9kl2L1DAUhoso7rLuH_BCAt54U81nm3ohDIMfCwMKrtchk5x2MrTJmKQL81_8sWan67rrhYXQkvOcJ83hraqXBL8lmMl3iRPWyRpTWhbhtKZPqnNKhKwZkfLpg--z6jKlPS6P4JK05Hl1xhosBZX8vPp1HbVP1unBh5SdQc73o54mnUM8ojRvhxjmQ0J6Cn5Ah3Q0O6dzLKB1KUQLsdS8RXkHLqIII9xobwDlgGIYAfWzN9kF7_zwHmnkIWWwyOgEtQk-FwalPNsjCv2tA60237-t1siEXYj5RfWs12OCy7v3RfXj08fr9Zd68_Xz1Xq1qY3gONeWbMFKDD2BHhtuul5yAUISjImxgtm-JS3thZUt1lQ2FtOmKQ2i1cA0seyiulq8Nui9OkQ36XhUQTt12ghxUDqW4YygoIibBlhfpsc12E6TDlMBDbMdB8OK68PiOszbCayBckk9PpI-rni3U0O4UR1vGOGiCN7cCWL4OZd5qcklA-OoPYQ5KdqScnYnOlnQ1_-g-zBHX0Z1ogiRjOJC0YUyMaQUob__GYLVbZbUkiVVsqROWVK0NL16eI37lj_JKQBbgFRKfoD49-z_aH8DPXXYJg</recordid><startdate>20220909</startdate><enddate>20220909</enddate><creator>Byrne, Jonah F.</creator><creator>Healy, Colm</creator><creator>Mongan, David</creator><creator>Susai, Subash Raj</creator><creator>Zammit, Stan</creator><creator>Fӧcking, Melanie</creator><creator>Cannon, Mary</creator><creator>Cotter, David R.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7046-0630</orcidid><orcidid>https://orcid.org/0000-0002-6299-2952</orcidid><orcidid>https://orcid.org/0000-0003-4308-0648</orcidid><orcidid>https://orcid.org/0000-0001-7931-9636</orcidid></search><sort><creationdate>20220909</creationdate><title>Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort</title><author>Byrne, Jonah F. ; Healy, Colm ; Mongan, David ; Susai, Subash Raj ; Zammit, Stan ; Fӧcking, Melanie ; Cannon, Mary ; Cotter, David R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>13/21</topic><topic>631/378</topic><topic>692/53</topic><topic>692/699/476/1414</topic><topic>692/699/476/1799</topic><topic>Adult</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Case-Control Studies</topic><topic>Clinical trials</topic><topic>Cohort Studies</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mental disorders</topic><topic>Mental Disorders - diagnosis</topic><topic>Neurosciences</topic><topic>Pharmacotherapy</topic><topic>Psychiatry</topic><topic>Psychosis</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Receptors, Urokinase Plasminogen Activator</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Byrne, Jonah F.</creatorcontrib><creatorcontrib>Healy, Colm</creatorcontrib><creatorcontrib>Mongan, David</creatorcontrib><creatorcontrib>Susai, Subash Raj</creatorcontrib><creatorcontrib>Zammit, Stan</creatorcontrib><creatorcontrib>Fӧcking, Melanie</creatorcontrib><creatorcontrib>Cannon, Mary</creatorcontrib><creatorcontrib>Cotter, David R.</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Translational psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Byrne, Jonah F.</au><au>Healy, Colm</au><au>Mongan, David</au><au>Susai, Subash Raj</au><au>Zammit, Stan</au><au>Fӧcking, Melanie</au><au>Cannon, Mary</au><au>Cotter, David R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort</atitle><jtitle>Translational psychiatry</jtitle><stitle>Transl Psychiatry</stitle><addtitle>Transl Psychiatry</addtitle><date>2022-09-09</date><risdate>2022</risdate><volume>12</volume><issue>1</issue><spage>377</spage><epage>377</epage><pages>377-377</pages><artnum>377</artnum><issn>2158-3188</issn><eissn>2158-3188</eissn><abstract>Individuals with psychotic disorders and depressive disorder exhibit altered concentrations of peripheral inflammatory markers. It has been suggested that clinical trials of anti-inflammatory therapies for psychiatric disorders should stratify patients by their inflammatory profile. Hence, we investigated whether different subgroups of individuals exist across psychiatric disorders, based on their inflammatory biomarker signatures. We measured the plasma concentrations of 17 inflammatory markers and receptors in 380 participants with psychotic disorder, depressive disorder or generalised anxiety disorder and 399 controls without psychiatric symptoms from the ALSPAC cohort at age 24. We employed a semi-supervised clustering algorithm, which discriminates multiple clusters of psychiatric disorder cases from controls. The best fit was for a two-cluster model of participants with psychiatric disorders (Adjusted Rand Index (ARI) = 0.52 ± 0.01) based on the inflammatory markers. Permutation analysis indicated the stability of the clustering solution performed better than chance (ARI = 0.43 ± 0.11; p  &lt; 0.001), and the clusters explained the inflammatory marker data better than a Gaussian distribution ( p  = 0.021). Cluster 2 exhibited marked increases in sTNFR1/2, suPAR, sCD93 and sIL-2RA, compared to cluster 1. Participants in the cluster exhibiting higher inflammation were less likely to be in employment, education or training, indicating poorer role functioning. This study found evidence for a novel pattern of inflammatory markers specific to psychiatric disorders and strongly associated with a transdiagnostic measure of illness severity. sTNFR1/2, suPAR, sCD93 and sIL-2RA could be used to stratify clinical trials of anti-inflammatory therapies for psychiatric disorders.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>36085284</pmid><doi>10.1038/s41398-022-02142-2</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0002-7046-0630</orcidid><orcidid>https://orcid.org/0000-0002-6299-2952</orcidid><orcidid>https://orcid.org/0000-0003-4308-0648</orcidid><orcidid>https://orcid.org/0000-0001-7931-9636</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2158-3188
ispartof Translational psychiatry, 2022-09, Vol.12 (1), p.377-377, Article 377
issn 2158-3188
2158-3188
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_e5e566e3f2844aed9a19025e63d94ec3
source Nexis UK; Publicly Available Content Database; PubMed Central; Springer Nature - nature.com Journals - Fully Open Access
subjects 13/21
631/378
692/53
692/699/476/1414
692/699/476/1799
Adult
Behavioral Sciences
Biological Psychology
Case-Control Studies
Clinical trials
Cohort Studies
Humans
Medicine
Medicine & Public Health
Mental disorders
Mental Disorders - diagnosis
Neurosciences
Pharmacotherapy
Psychiatry
Psychosis
Psychotic Disorders - diagnosis
Receptors, Urokinase Plasminogen Activator
Young Adult
title Transdiagnostic inflammatory subgroups among psychiatric disorders and their relevance to role functioning: a nested case-control study of the ALSPAC cohort
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T20%3A53%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Transdiagnostic%20inflammatory%20subgroups%20among%20psychiatric%20disorders%20and%20their%20relevance%20to%20role%20functioning:%20a%20nested%20case-control%20study%20of%20the%20ALSPAC%20cohort&rft.jtitle=Translational%20psychiatry&rft.au=Byrne,%20Jonah%20F.&rft.date=2022-09-09&rft.volume=12&rft.issue=1&rft.spage=377&rft.epage=377&rft.pages=377-377&rft.artnum=377&rft.issn=2158-3188&rft.eissn=2158-3188&rft_id=info:doi/10.1038/s41398-022-02142-2&rft_dat=%3Cproquest_doaj_%3E2712849598%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c540t-d1bed80ef1ef0c4c9f845e581001cd53df7172f5d870a286d0266d8057ae3a1d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2712118320&rft_id=info:pmid/36085284&rfr_iscdi=true